I-Mab
NASDAQ:IMAB

Watchlist Manager

I-Mab

NASDAQ:IMAB

Watchlist

Dividends

Price: 1.02 USD 4.62%

Market Cap: 82.5m USD

Have any thoughts about
I-Mab?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication

Add Price Alert

Price Target:

Last Price: 1.02 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

IMAB Alert

I-Mab

1.02

+0.045 (+4.62%)

52 Week Range	0.9322 2.37
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

I-Mab

What unique competitive advantages
does I-Mab hold over its rivals?

What risks and challenges
does I-Mab face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of I-Mab.

What unique competitive advantages
does I-Mab hold over its rivals?

What risks and challenges
does I-Mab face in the near future?

Summarize the latest earnings call
of I-Mab.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for I-Mab.

Provide P/S
for I-Mab.

Provide P/E
for I-Mab.

Provide P/OCF
for I-Mab.

Provide P/FCFE
for I-Mab.

Provide P/B
for I-Mab.

Provide EV/S
for I-Mab.

Provide EV/GP
for I-Mab.

Provide EV/EBITDA
for I-Mab.

Provide EV/EBIT
for I-Mab.

Provide EV/OCF
for I-Mab.

Provide EV/FCFF
for I-Mab.

Provide EV/IC
for I-Mab.

Show me price targets
for I-Mab made by professional analysts.

What are the Revenue projections
for I-Mab?

How accurate were the past Revenue estimates
for I-Mab?

What are the Net Income projections
for I-Mab?

How accurate were the past Net Income estimates
for I-Mab?

What are the EPS projections
for I-Mab?

How accurate were the past EPS estimates
for I-Mab?

What are the EBIT projections
for I-Mab?

How accurate were the past EBIT estimates
for I-Mab?

Compare the revenue forecasts
for I-Mab with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of I-Mab and its key competitors using the latest financial data.

Compare historical revenue growth rates
of I-Mab against its competitors.

Analyze the profit margins
(gross, operating, and net) of I-Mab compared to its peers.

Compare the P/E ratios
of I-Mab against its peers.

Discuss the investment returns and shareholder value creation
comparing I-Mab with its peers.

Analyze the financial leverage
of I-Mab compared to its main competitors.

Show all profitability ratios
for I-Mab.

Provide ROE
for I-Mab.

Provide ROA
for I-Mab.

Provide ROIC
for I-Mab.

Provide ROCE
for I-Mab.

Provide Gross Margin
for I-Mab.

Provide Operating Margin
for I-Mab.

Provide Net Margin
for I-Mab.

Provide FCF Margin
for I-Mab.

Show all solvency ratios
for I-Mab.

Provide D/E Ratio
for I-Mab.

Provide D/A Ratio
for I-Mab.

Provide Interest Coverage Ratio
for I-Mab.

Provide Altman Z-Score Ratio
for I-Mab.

Provide Quick Ratio
for I-Mab.

Provide Current Ratio
for I-Mab.

Provide Cash Ratio
for I-Mab.

What is the historical Revenue growth
over the last 5 years for I-Mab?

What is the historical Net Income growth
over the last 5 years for I-Mab?

What is the current Free Cash Flow
of I-Mab?

Discuss the annual earnings per share (EPS)
trend over the past five years for I-Mab.

IMAB

Balance Sheet

Long-Term Debt

I-Mab
Long-Term Debt

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

Adjust for Inflation

I-Mab
Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

	Long-Term Debt	CAGR 3Y	CAGR 5Y	CAGR 10Y
I-Mab NASDAQ:IMAB	Long-Term Debt N/A	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
Beigene Ltd HKEX:6160	Long-Term Debt ¥1.6B	CAGR 3-Years 4%	CAGR 5-Years 41%	CAGR 10-Years N/A
Innovent Biologics Inc HKEX:1801	Long-Term Debt ¥2.3B	CAGR 3-Years 17%	CAGR 5-Years 24%	CAGR 10-Years N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd SSE:603392	Long-Term Debt ¥127.7m	CAGR 3-Years N/A	CAGR 5-Years 43%	CAGR 10-Years N/A
Chongqing Zhifei Biological Products Co Ltd SZSE:300122	Long-Term Debt ¥398.2m	CAGR 3-Years 65%	CAGR 5-Years N/A	CAGR 10-Years N/A
Imeik Technology Development Co Ltd SZSE:300896	Long-Term Debt ¥37.5m	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A

No Stocks Found

I-Mab
Glance View

Market Cap

82.5m USD

Industry

Biotechnology

I-Mab operates as a clinical stage biopharmaceutical company. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2020-01-17.

Open IMAB Analysis

IMAB Intrinsic Value

0.75 USD

Overvaluation 27%

Intrinsic Value

Price

What is Intrinsic Value?

	Franklin Covey Co NYSE:FC	36.92 USD -1.47%
	Mohawk Industries Inc NYSE:MHK	134.36 USD -1.45%
	Ardmore Shipping Corp NYSE:ASC	11.34 USD 1.52%
	ASGN Inc NYSE:ASGN	90.33 USD -1.89%
	Skyworks Solutions Inc NASDAQ:SWKS	87.41 USD -1.22%
	Weatherford International PLC NASDAQ:WFRD	82.96 USD -0.81%

	Johnson & Johnson NYSE:JNJ	153.28 USD -0.98%
	Bank of America Corp NYSE:BAC	46.885 USD -0.33%
	Mastercard Inc NYSE:MA	528.195 USD -0.6%
	Salesforce Inc NYSE:CRM	329.5975 USD -0.43%
	Abbvie Inc NYSE:ABBV	182.4607 USD 0.38%
	Home Depot Inc NYSE:HD	427.33 USD 0.09%

	Arista Networks Inc NYSE:ANET	412.68 USD 0.63%
	Visa Inc NYSE:V	314.77 USD -0.59%
	Texas Pacific Land Corp NYSE:TPL	1 537.765 USD 2.49%
	KLA Corp NASDAQ:KLAC	662.605 USD -0.51%
	Manhattan Associates Inc NASDAQ:MANH	295.1 USD 3.05%
	Pinduoduo Inc NASDAQ:PDD	98.675 USD -0.31%

	Salesforce Inc NYSE:CRM	329.5975 USD -0.43%
	Accenture PLC NYSE:ACN	349.49 USD -3.29%
	ServiceNow Inc NYSE:NOW	1 048.71 USD 0.03%
	EOG Resources Inc NYSE:EOG	132.27 USD 0.78%
	Monster Beverage Corp NASDAQ:MNST	54.48 USD -0.91%
	Copart Inc NASDAQ:CPRT	61.91 USD -0.18%

I-Mab
NASDAQ:IMAB

I-Mab
Long-Term Debt

I-Mab
Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

I-Mab
Glance View

See Also

Company

Help

Tools

Stocks

I-Mab NASDAQ:IMAB

I-Mab Long-Term Debt

I-Mab Long-Term Debt Peer Comparison

Competitors Analysis Latest Figures & CAGR of Competitors

I-Mab Glance View

See Also

Company

Help

Tools

Stocks

I-Mab
NASDAQ:IMAB

I-Mab
Long-Term Debt

I-Mab
Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

I-Mab
Glance View